Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency: A Family Guide

Note: This family and caregiver guide complements—not replaces—the individualized emergency letter and advice from the treating metabolic center. Recommendations are derived from rare-case series and general hyperammonemia guidance (Last reviewed: November 2026).

Hyperammonemic encephalopathy due to carbonic anhydrase VA (CA-VA) deficiency is an ultra-rare metabolic disorder that affects the body’s ability to clear toxins and maintain energy balance ^[1]. At its core, this condition is caused by a shortage of bicarbonate inside the mitochondria, the energy-producing centers of the cells ^[2]. Without enough bicarbonate, several critical enzymes—most notably those that remove ammonia (a toxic byproduct) from the blood—cannot function correctly, leading to a “supply chain” breakdown in the body’s chemistry ^[3].

This condition is autosomal recessive, meaning it occurs only when a child inherits two non-working copies of the CA5A gene (one from each parent) ^[4]. Because it is so rare, many families experience a “diagnostic odyssey” before finding the right answers. However, a precise genetic diagnosis is a turning point, as it allows for targeted management that may reduce risk, though severity and neurological outcomes vary ^[5].

Reported cases often present in the newborn period, although later and milder presentations occur ^[4]. These episodes are frequently triggered by the stress of a common illness, a fever, or going too long without food, which causes the body to break down its own tissue for energy (catabolism) ^[6]. During a crisis, ammonia and acid build up in the bloodstream, leading to symptoms like extreme sleepiness, vomiting, or confusion, a state of brain dysfunction known as encephalopathy ^[7].

The most vital aspects of living with CA-VA deficiency revolve around proactive prevention and rapid emergency response. Caregivers play a central role by ensuring children eat frequently to avoid fasting and by initiating a specialized “sick-day protocol” at the first sign of illness ^[5]. In a hospital setting, acute crises require immediate management with medications like carglumic acid, an analogue that activates the first step of the urea cycle to support residual activity ^[2][8]. High-dose IV dextrose (intravenous sugar) is also used to stop the metabolic stress. While the journey involves constant vigilance, early recognition and treatment may reduce risk, but there is no promise of a cure and the evidence is limited ^[7].